Physician profile
Paul Gray Ruff, IV
NPI 1235102682
$398,581.33
in general payments reported to CMS, 2019-2025
13 companies · $24K in 2025
The $24K reported for 2025 was more than what 97% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $180K · 2020: $56K · 2021: $31K · 2022: $52K · 2023: $28K · 2024: $28K · 2025: $24K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $74K · Honoraria: $2,300 · Food and Beverage: $2,019 · Travel and Lodging: $1,188.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $74,350.00 |
| Honoraria | $2,300.00 |
| Food and Beverage | $2,019.25 |
| Travel and Lodging | $1,188.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $163,672.25 | 2019-2025 | |
| Apyx Medical Corporation | $152,510.74 | 2019-2020 | |
| Abbvie INC. | $40,060.60 | 2023-2025 | Botox |
| Allergan, INC. | $25,346.28 | 2019-2022 | |
| Solta Medical, A Division of Bausch Health US, LLC | $13,343.75 | 2019-2023 | |
| Pacira Pharmaceuticals Incorporated | $2,565.53 | 2023-2025 | Iovera, Exparel |
| Merz North America, INC. | $499.87 | 2019-2023 | Xeomin |
| Mentor Worldwide LLC | $233.06 | 2023-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander, Mentor Siltex Round Spectrum |
| Baxter Healthcare | $215.14 | 2023-2024 | Artiss, Perclot, Floseal |
| Integra Lifesciences Corporation | $47.23 | 2024-2025 | Integra, Surgimend, Integra Dermal Regeneration Template |
| Motiva USA, LLC | $41.49 | 2025 | |
| Bard Peripheral Vascular, INC. | $29.19 | 2021 | |
| Smith+Nephew, INC. | $16.20 | 2025 | Pico 7 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Ruff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.